Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Restoring contractile function in myocardial scars is a significant clinical challenge.
• Current treatments for myocardial infarction have limitations in promoting cardiac tissue regeneration.

Purpose of the Study:

• To design and evaluate a novel bioimplant for cardiac regeneration using progenitor cells, peptide hydrogel, and a porous elastomeric scaffold.
• To assess the efficacy of the bioimplant in a mouse model of myocardial infarction.

Main Methods:

• Subcutaneous adipose tissue-derived progenitor cells (subATDPCs) were engineered to express reporter genes.
• Cells were seeded into a scaffold (polycaprolactone methacryloyloxyethyl ester) containing peptide hydrogel (PuraMatrix™).
• The engineered bioimplant was transplanted onto the injured myocardium in a mouse model.

Main Results:

• Bioluminescence and fluorescence imaging confirmed promoter expression in the transplanted cells.
• The bioimplant integrated well with the host tissue, with vascularization observed at the interface.
• Echocardiography demonstrated a positive impact on cardiac function post-treatment.

Conclusions:

• The developed bioimplant is a promising construct for supporting myocardial regeneration.
• This approach offers a potential new strategy for treating heart damage after myocardial infarction.